Ptc Therapeutics Inc (PTCT)

09:21 AM

PTC Therapeutics Hits New 52-Week High of $69.26, Up 82.16% - Markets Mojo

09:21 AM

03:16 AM

Using RSI to spot recovery in PTC Therapeutics Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - newser.com

03:16 AM

Oct 15, 2025

Is PTC Therapeutics Inc a good long term investmentStock Market Trends & Affordable Trading Strategies - earlytimes.in

Oct 15, 2025

Oct 15, 2025

PTC Therapeutics (NASDAQ:PTCT) Climbs with Nasdaq 100 Index Trend - Kalkine Media

Oct 15, 2025

Oct 15, 2025

PTC Therapeutics (NASDAQ:PTCT) Sets New 52-Week HighHere's What Happened - MarketBeat

Oct 15, 2025

Oct 15, 2025

Can PTC Therapeutics Inc. stock reach $100 price targetStop Loss & Long-Term Safe Investment Ideas - newser.com

Oct 15, 2025

Oct 15, 2025

Using flow based indicators on PTC Therapeutics Inc.Market Trend Report & Fast Momentum Stock Entry Tips - newser.com

Oct 15, 2025

Oct 15, 2025

Is PTC Therapeutics Inc. (BH3) stock among top earnings playsJuly 2025 Earnings & Low Risk Entry Point Guides - newser.com

Oct 15, 2025

Oct 15, 2025

Ptc Therapeutics stock hits 52-week high at 67.43 USD By Investing.com - Investing.com Canada

Oct 15, 2025

Oct 15, 2025

PTC Therapeutics (NASDAQ:PTCT) Nasdaq Futures Rare Disease Focus - Kalkine Media

Oct 15, 2025

Oct 14, 2025

PTC Therapeutics, Inc. $PTCT Shares Purchased by Bayforest Capital Ltd - MarketBeat

Oct 14, 2025

Oct 14, 2025

How PTC Therapeutics Inc. stock compares to growth peersJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

What does recent volatility data suggest for PTC Therapeutics Inc.2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Oct 14, 2025

Oct 14, 2025

Relative strength of PTC Therapeutics Inc. in sector analysisMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com

Oct 14, 2025

Oct 14, 2025

Live market analysis of PTC Therapeutics Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com

Oct 14, 2025

Oct 13, 2025

PTC Therapeutics upgraded at BofA on FDA review for Friedreich's ataxia drug - MSN

Oct 13, 2025

Oct 13, 2025

Leerink Partnrs Issues Positive Outlook for PTCT Earnings - MarketBeat

Oct 13, 2025

Oct 11, 2025

PTC Therapeutics, Inc. Hits New 52-Week High of $67.40 - Markets Mojo

Oct 11, 2025

Oct 10, 2025

Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 3,375 Shares of Stock - MarketBeat

Oct 10, 2025

Oct 10, 2025

PTC Therapeutics' (PTCT) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Chart based analysis of PTC Therapeutics Inc. trendsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Ptc Therapeutics exec. VP Boulding sells $214k in shares By Investing.com - Investing.com Canada

Oct 10, 2025

Oct 09, 2025

Robeco Institutional Asset Management B.V. Buys Shares of 5,733 PTC Therapeutics, Inc. $PTCT - MarketBeat

Oct 09, 2025

Oct 08, 2025

RBC Raises Price Target on PTC Therapeutics to $70 From $63, Keeps Outperform Rating - MarketScreener

Oct 08, 2025

Oct 07, 2025

Mark Elliott Boulding Sells 2,266 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat

Oct 07, 2025

Oct 07, 2025

Mark Elliott Boulding Sells 22,655 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat

Oct 07, 2025

Oct 07, 2025

PTC Therapeutics (NASDAQ:PTCT) Insider Sells $3,632,750.00 in Stock - MarketBeat

Oct 07, 2025

Oct 07, 2025

Allan Jacobson sells PTC Therapeutics shares for $780,000 - Investing.com

Oct 07, 2025

Oct 07, 2025

Ptc therapeutics exec. VP Boulding sells $1.6m in stock - Investing.com

Oct 07, 2025

Oct 07, 2025

Emma Reeve, PTC Therapeutics director, sells $1.68m in shares - Investing.com

Oct 07, 2025

Oct 07, 2025

Duchenne Muscular Dystrophy Market Report 2034: Epidemiology, Pipeline Therapies, and Recent Regulatory Approvals by DelveInsight | Featuring Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, S - Barchart.com

Oct 07, 2025

Oct 07, 2025

Allan Steven Jacobson Sells 12,000 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat

Oct 07, 2025

Oct 06, 2025

Real time breakdown of PTC Therapeutics Inc. stock performance2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com

Oct 06, 2025

Oct 06, 2025

Evaluating PTC Therapeutics Inc. with trendline analysisJuly 2025 Setups & Verified Technical Signals - newser.com

Oct 06, 2025

Oct 05, 2025

PTC Therapeutics Stock Sees Momentum Amidst Corporate Developments - StocksToTrade

Oct 05, 2025

Oct 05, 2025

PTC Therapeutics Bolsters Workforce Amid Stock Option Grants - timothysykes.com

Oct 05, 2025

Oct 05, 2025

Analysts Shine Spotlight on PTCT in Friedreich’s Ataxia Talks - timothysykes.com

Oct 05, 2025

Oct 05, 2025

Why PTC Therapeutics Inc. (BH3) stock could outperform next yearDollar Strength & Reliable Intraday Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Will PTC Therapeutics Inc. (BH3) stock outperform energy sector in 2025 - newser.com

Oct 05, 2025

Oct 05, 2025

How to build a custom watchlist for PTC Therapeutics Inc.Quarterly Portfolio Review & High Conviction Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Will PTC Therapeutics Inc. rebound enough to break evenCEO Change & Weekly Momentum Picks - newser.com

Oct 05, 2025

Oct 04, 2025

PTC Therapeutics Announces New Employee Stock Grants Amid Strategic Developments - timothysykes.com

Oct 04, 2025

Oct 04, 2025

PTCT Sees Strategic Staff Expansion Amidst Recent Developments - timothysykes.com

Oct 04, 2025